RESUMEN
Zika virus (ZIKV) has caused substantial concern worldwide owing to its association with severe birth defects, such as microcephaly and other congenital malformations. Inflammasomes, i.e., multi-protein complexes that induce inflammation and pyroptosis, are predicted to contribute to the immune response to this flavivirus. Accordingly, in this study, the in situ inflammasome response was evaluated in fatal cases of ZIKV-linked microcephaly. Brain tissue samples were collected from eight babies, including four ZIKV-positive microcephalic neonates who died after birth and four flavivirus-negative neonatal controls who died of other causes and whose central nervous system (CNS) architecture was preserved. In the ZIKV-positive newborn/stillbirth babies, the major histopathological alterations included atrophy of the cortical layer, a predominance of mononuclear cell infiltration in the Virchow-Robin space, neuronal necrosis, vacuolization and neuronal degeneration, neuronophagy, and gliosis. An immunohistochemical analysis of tissues in the neural parenchyma showed significantly higher expression of the receptors NLRP1, NLRP3, and AIM2, cytokines IL-1ß, IL-18, and IL-33, and enzymes caspase 1, iNOS, and arginase 1 in ZIKV-positive microcephaly cases than in flavivirus-negative controls. These results suggest that inflammasome activation can aggravate the neuroinflammatory response and consequently increase CNS damage in neonates with fetal neural ZIKV infection and microcephaly.
Asunto(s)
Sistema Nervioso Central/patología , Sistema Nervioso Central/virología , Inflamasomas/fisiología , Microcefalia/patología , Microcefalia/virología , Infección por el Virus Zika/patología , Virus Zika/patogenicidad , Encéfalo/metabolismo , Encéfalo/patología , Encéfalo/virología , Sistema Nervioso Central/metabolismo , Citocinas/metabolismo , Femenino , Feto/metabolismo , Feto/virología , Humanos , Recién Nacido , Inflamasomas/metabolismo , Masculino , Microcefalia/metabolismo , Embarazo , Complicaciones Infecciosas del Embarazo/metabolismo , Complicaciones Infecciosas del Embarazo/patología , Complicaciones Infecciosas del Embarazo/virología , Infección por el Virus Zika/metabolismo , Infección por el Virus Zika/virologíaRESUMEN
OBJECTIVE: To describe timely vaccination completion and obstacles in the first 24 months of life in Brazil, examining associations with maternal race/skin color. METHODS: Study participants were 37,801 children born in 2017 and 2018 included in the National Immunization Coverage Survey. We calculated prevalence and 95% confidence intervals for timely vaccine completeness and obstacles at 5, 12 and 24 months of life, according to maternal race/skin color. Associations were analyzed using logistic regression. RESULTS: 7.2% (95%CI 6.3;8.2) of mothers faced difficulties in taking their children to be vaccinated, and 23.4% (95%CI 21.7;25.1) were not vaccinated when taken. These proportions were 75% (95%CI 1.25;2.45) and 97% (95%CI 1.57;2.48) higher, respectively, among Black mothers. At least one vaccination was delayed among 49.9% (95%CI 47.8;51.9) and 61.1% (95%CI 59.2;63.0) of children by 5 and 12 months, respectively. These rates were higher among Black/mixed race mothers. CONCLUSION: There are racial inequalities in both the obstacles faced and in vaccination rates in Brazil. MAIN RESULTS: Marked racial inequalities were found in the obstacles to vaccination of children under 24 months in Brazil and to timely vaccination at 5 months and in the first year of life. IMPLICATIONS FOR SERVICES: Racial inequalities in the occurrence of vaccination shortcomings in health services, in the objective restrictions faced by families in taking their children to vaccination centers and in incomplete vaccination in a timely manner need to be addressed by the Brazilian National Health System. PERSPECTIVES: Equal public policies to address barriers to vaccination and qualification of health services need to be implemented. Studies need to deepen understanding of the structural determinants that lead to racial disparities.
Asunto(s)
Disparidades en Atención de Salud , Madres , Vacunación , Humanos , Brasil , Lactante , Vacunación/estadística & datos numéricos , Femenino , Estudios Retrospectivos , Disparidades en Atención de Salud/estadística & datos numéricos , Madres/estadística & datos numéricos , Preescolar , Masculino , Cobertura de Vacunación/estadística & datos numéricos , Recién Nacido , Adulto , Estudios de Cohortes , Factores Socioeconómicos , Población Negra/estadística & datos numéricos , Factores de Tiempo , Programas de Inmunización/estadística & datos numéricos , Accesibilidad a los Servicios de Salud/estadística & datos numéricos , Adulto Joven , Población Blanca/estadística & datos numéricosRESUMEN
OBJECTIVE: The national vaccination coverage survey on full vaccination at 12 and 24 months of age was carried out to investigate drops in coverage as of 2016. METHODS: A sample of 37,836 live births from the 2017 or 2018 cohorts living in capital cities, the Federal District, and 12 inner cities with 100 thousand inhabitants were followed for the first 24 months through vaccine record cards. Census tracts stratified according to socioeconomic levels had the same number of children included in each stratum. Coverage for each vaccine, full vaccination at 12 and 24 months and number of doses administered, valid and timely, were calculated. Family, maternal and child factors associated with coverage were surveyed. The reasons for not vaccinating analyzed were: medical contraindications, access difficulties, problems with the program, and vaccine hesitancy. RESULTS: Preliminary results showed that less than 1% of children were not vaccinated, full coverage was less than 75% at all capitals and the Federal District, vaccines requiring more than one dose progressively lost coverage, and there were inequalities among socioeconomic strata, favorable to the highest level in some cities and to the lowest in others. CONCLUSION: There was an actual reduction in full vaccination in all capitals and the Federal District for children born in 2017 and 2018, showing a deteriorating implementation of the National Immunization Program from 2017 to 2019. The survey did not measure the impacts of the COVID-19 pandemic, which may have further reduced vaccination coverage.
Asunto(s)
COVID-19 , Cobertura de Vacunación , Vacunas , Niño , Humanos , Lactante , Brasil , Pandemias , VacunaciónRESUMEN
Background: Knowledge regarding the risks associated with Zika virus (ZIKV) infections in pregnancy has relied on individual studies with relatively small sample sizes and variable risk estimates of adverse outcomes, or on surveillance or routinely collected data. Using data from the Zika Brazilian Cohorts Consortium, this study aims, to estimate the risk of adverse outcomes among offspring of women with RT-PCR-confirmed ZIKV infection during pregnancy and to explore heterogeneity between studies. Methods: We performed an individual participant data meta-analysis of the offspring of 1548 pregnant women from 13 studies, using one and two-stage meta-analyses to estimate the absolute risks. Findings: Of the 1548 ZIKV-exposed pregnancies, the risk of miscarriage was 0.9%, while the risk of stillbirth was 0.3%. Among the pregnancies with liveborn children, the risk of prematurity was 10,5%, the risk of low birth weight was 7.7, and the risk of small for gestational age (SGA) was 16.2%. For other abnormalities, the absolute risks were: 2.6% for microcephaly at birth or first evaluation, 4.0% for microcephaly at any time during follow-up, 7.9% for neuroimaging abnormalities, 18.7% for functional neurological abnormalities, 4.0% for ophthalmic abnormalities, 6.4% for auditory abnormalities, 0.6% for arthrogryposis, and 1.5% for dysphagia. This risk was similar in all sites studied and in different socioeconomic conditions, indicating that there are not likely to be other factors modifying this association. Interpretation: This study based on prospectively collected data generates the most robust evidence to date on the risks of congenital ZIKV infections over the early life course. Overall, approximately one-third of liveborn children with prenatal ZIKV exposure presented with at least one abnormality compatible with congenital infection, while the risk to present with at least two abnormalities in combination was less than 1.0%.
RESUMEN
Despite great advances in our knowledge of the consequences of Zika virus to human health, many questions remain unanswered, and results are often inconsistent. The small sample size of individual studies has limited inference about the spectrum of congenital Zika manifestations and the prognosis of affected children. The Brazilian Zika Cohorts Consortium addresses these limitations by bringing together and harmonizing epidemiological data from a series of prospective cohort studies of pregnant women with rash and of children with microcephaly and/or other manifestations of congenital Zika. The objective is to estimate the absolute risk of congenital Zika manifestations and to characterize the full spectrum and natural history of the manifestations of congenital Zika in children with and without microcephaly. This protocol describes the assembly of the Consortium and protocol for the Individual Participant Data Meta-analyses (IPD Meta-analyses). The findings will address knowledge gaps and inform public policies related to Zika virus. The large harmonized dataset and joint analyses will facilitate more precise estimates of the absolute risk of congenital Zika manifestations among Zika virus-infected pregnancies and more complete descriptions of its full spectrum, including rare manifestations. It will enable sensitivity analyses using different definitions of exposure and outcomes, and the investigation of the sources of heterogeneity between studies and regions.
Asunto(s)
Exposición Materna/estadística & datos numéricos , Metaanálisis como Asunto , Participación del Paciente/estadística & datos numéricos , Complicaciones Infecciosas del Embarazo/virología , Infección por el Virus Zika/congénito , Brasil/epidemiología , Preescolar , Protocolos Clínicos , Femenino , Humanos , Lactante , Recién Nacido , Microcefalia/epidemiología , Microcefalia/virología , Embarazo , Estudios Prospectivos , Infección por el Virus Zika/complicaciones , Infección por el Virus Zika/epidemiologíaRESUMEN
Brazil has experienced an unprecedented epidemic of Zika virus (ZIKV), with ~30,000 cases reported to date. ZIKV was first detected in Brazil in May 2015, and cases of microcephaly potentially associated with ZIKV infection were identified in November 2015. We performed next-generation sequencing to generate seven Brazilian ZIKV genomes sampled from four self-limited cases, one blood donor, one fatal adult case, and one newborn with microcephaly and congenital malformations. Results of phylogenetic and molecular clock analyses show a single introduction of ZIKV into the Americas, which we estimated to have occurred between May and December 2013, more than 12 months before the detection of ZIKV in Brazil. The estimated date of origin coincides with an increase in air passengers to Brazil from ZIKV-endemic areas, as well as with reported outbreaks in the Pacific Islands. ZIKV genomes from Brazil are phylogenetically interspersed with those from other South American and Caribbean countries. Mapping mutations onto existing structural models revealed the context of viral amino acid changes present in the outbreak lineage; however, no shared amino acid changes were found among the three currently available virus genomes from microcephaly cases. Municipality-level incidence data indicate that reports of suspected microcephaly in Brazil best correlate with ZIKV incidence around week 17 of pregnancy, although this correlation does not demonstrate causation. Our genetic description and analysis of ZIKV isolates in Brazil provide a baseline for future studies of the evolution and molecular epidemiology of this emerging virus in the Americas.
Asunto(s)
Brotes de Enfermedades , Microcefalia/epidemiología , Infección por el Virus Zika/epidemiología , Infección por el Virus Zika/virología , Virus Zika/genética , Aedes/virología , Américas/epidemiología , Animales , Femenino , Genoma Viral/genética , Humanos , Incidencia , Insectos Vectores/virología , Microcefalia/virología , Epidemiología Molecular , Datos de Secuencia Molecular , Mutación , Islas del Pacífico/epidemiología , Filogenia , Embarazo , ARN Viral/genética , Análisis de Secuencia de ARN , Viaje , Virus Zika/clasificación , Virus Zika/aislamiento & purificación , Infección por el Virus Zika/transmisiónRESUMEN
This study aimed to show, based on the literature on the subject, the potential for dispersal and establishment of the chikungunya virus in Brazil. The chikungunya virus, a Togaviridae member of the genusAlphavirus, reached the Americas in 2013 and, the following year, more than a million cases were reported. In Brazil, indigenous transmission was registered in Amapa and Bahia States, even during the period of low rainfall, exposing the whole country to the risk of virus spreading. Brazil is historically infested by Ae. aegypti and Ae. albopictus, also dengue vectors. Chikungunya may spread, and it is important to take measures to prevent the virus from becoming endemic in the country. Adequate care for patients with chikungunya fever requires training general practitioners, rheumatologists, nurses, and experts in laboratory diagnosis. Up to November 2014, more than 1,000 cases of the virus were reported in Brazil. There is a need for experimental studies in animal models to understand the dynamics of infection and the pathogenesis as well as to identify pathophysiological mechanisms that may contribute to identifying effective drugs against the virus. Clinical trials are needed to identify the causal relationship between the virus and serious injuries observed in different organs and joints. In the absence of vaccines or effective drugs against the virus, currently the only way to prevent the disease is vector control, which will also reduce the number of cases of dengue fever.
Asunto(s)
Aedes/clasificación , Fiebre Chikungunya/epidemiología , Virus Chikungunya , Insectos Vectores/clasificación , Animales , Brasil , Fiebre Chikungunya/transmisión , Notificación de Enfermedades , Humanos , Factores de RiesgoRESUMEN
BACKGROUND: There is a gap in knowledge on the growth of children exclusively breastfed during the fifth and sixth months of life. This study aimed to assess the growth of infants who were exclusively breastfed for the first 6 months of life and compare the distributions of anthropometric measures based on the National Center for Health Statistics (NCHS, 1977) and World Health Organization (WHO, 2006) curves. METHODS: Cross-sectional study that measured the weight and length of 360 healthy and exclusively breastfed infants who were enrolled in a primary care program in Belem, Brazil from October 2006 to December 2008. The children were evenly grouped into age groups from 1 to 6 months of age. RESULTS: The mean weights were higher than the NCHS, 1977 mean weight for all of the studied groups regardless of gender and showed greater similarity to the WHO, 2006 mean weight, especially when standard deviations were considered. Regarding length, although the average length at birth was smaller, females had higher averages in the second and sixth months compared with the reference curves (p < 0.05). CONCLUSIONS: Exclusive breastfeeding in the first 6 months of life provides adequate physical growth, resulting in height and weight gain curves that are similar to or greater than the NCHS, 1977 and WHO, 2006 curves. The greater mean weight at the fifth and sixth months of life suggests that the second-quarter growth curves of children who are exclusively breastfed are greater than those of children who receive other types of food.
RESUMEN
BACKGROUND: Dengue is an increasing public health concern in Brazil. There is a need for an updated evaluation of the economic impact of dengue within the country. We undertook this multicenter study to evaluate the economic burden of dengue in Brazil. METHODS: We estimated the economic burden of dengue in Brazil for the years 2009 to 2013 and for the epidemic season of August 2012- September 2013. We conducted a multicenter cohort study across four endemic regions: Midwest, Goiania; Southeast, Belo Horizonte and Rio de Janeiro; Northeast: Teresina and Recife; and the North, Belem. Ambulatory or hospitalized cases with suspected or laboratory-confirmed dengue treated in both the private and public sectors were recruited. Interviews were scheduled for the convalescent period to ascertain characteristics of the dengue episode, date of first symptoms/signs and recovery, use of medical services, work/school absence, household spending (out-of-pocket expense) and income lost using a questionnaire developed for a previous cost study. We also extracted data from the patients' medical records for hospitalized cases. Overall costs per case and cumulative costs were calculated from the public payer and societal perspectives. National cost estimations took into account cases reported in the official notification system (SINAN) with adjustment for underreporting of cases. We applied a probabilistic sensitivity analysis using Monte Carlo simulations with 90% certainty levels (CL). RESULTS: We screened 2,223 cases, of which 2,035 (91.5%) symptomatic dengue cases were included in our study. The estimated cost for dengue for the epidemic season (2012-2013) in the societal perspective was US$ 468 million (90% CL: 349-590) or US$ 1,212 million (90% CL: 904-1,526) after adjusting for under-reporting. Considering the time series of dengue (2009-2013) the estimated cost of dengue varied from US$ 371 million (2009) to US$ 1,228 million (2013). CONCLUSIONS: The economic burden associated with dengue in Brazil is substantial with large variations in reported cases and consequently costs reflecting the dynamic of dengue transmission.
Asunto(s)
Costo de Enfermedad , Dengue/economía , Absentismo , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Brasil/epidemiología , Niño , Preescolar , Dengue/epidemiología , Femenino , Gastos en Salud , Servicios de Salud/estadística & datos numéricos , Humanos , Lactante , Entrevistas como Asunto , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Adulto JovenRESUMEN
Norovirus (NoV), sapovirus (SaV) and human astrovirus (HAstV) are viral pathogens that are associated with outbreaks and sporadic cases of gastroenteritis. However, little is known about the occurrence of these pathogens in relatively isolated communities, such as the remnants of African-descendant villages ("Quilombola"). The objective of this study was the frequency determination of these viruses in children under 10 years, with and without gastroenteritis, from a "Quilombola" Community, Northern Brazil. A total of 159 stool samples were obtained from April/2008 to July/2010 and tested by an enzyme immunoassay (EIA) and reverse transcription-polymerase chain reaction (RT-PCR) to detect NoV, SaV and HAstV, and further molecular characterization was performed. These viruses were detected only in the diarrheic group. NoV was the most frequent viral agent detected (19.7%-16/81), followed by SaV (2.5%-2/81) and HAstV (1.2%-1/81). Of the 16 NoV-positive samples, 14 were sequenced with primers targeting the B region of the polymerase (ORF1) and the D region of the capsid (ORF2). The results showed a broad genetic diversity of NoV, with 12 strains being classified as GII-4 (5-41.7%), GII-6 (3-25%), GII-7 (2-16.7%), GII-17 (1-8.3%) and GI-2 (1-8.3%), as based on the polymerase region; 12 samples were classified, based on the capsid region, as GII-4 (6-50%, being 3-2006b variant and 3-2010 variant), GII-6 (3-25%), GII-17 (2-16.7%) and GII-20 (1-8.3%). One NoV-strain showed dual genotype specificity, based on the polymerase and capsid region (GII-7/GII-20). This study provides, for the first time, epidemiological and molecular information on the circulation of NoV, SaV and HAstV in African-descendant communities in Northern Brazil and identifies NoV genotypes that were different from those detected previously in studies conducted in the urban area of Belém. It remains to be determined why a broader NoV diversity was observed in such a semi-isolated community.
Asunto(s)
Población Negra/estadística & datos numéricos , Diarrea/etnología , Diarrea/virología , Variación Genética , Norovirus/genética , Norovirus/aislamiento & purificación , Animales , Brasil/etnología , Niño , Diarrea/complicaciones , Perros , Heces/virología , Gastroenteritis/complicaciones , Gastroenteritis/etnología , Gastroenteritis/virología , Humanos , Mamastrovirus/genética , Mamastrovirus/aislamiento & purificación , Mamastrovirus/fisiología , Norovirus/fisiología , Sapovirus/genética , Sapovirus/aislamiento & purificación , Sapovirus/fisiologíaRESUMEN
This study aimed to show, based on the literature on the subject, the potential for dispersal and establishment of the chikungunya virus in Brazil. The chikungunya virus, a Togaviridae member of the genusAlphavirus, reached the Americas in 2013 and, the following year, more than a million cases were reported. In Brazil, indigenous transmission was registered in Amapa and Bahia States, even during the period of low rainfall, exposing the whole country to the risk of virus spreading. Brazil is historically infested by Ae. aegypti and Ae. albopictus, also dengue vectors. Chikungunya may spread, and it is important to take measures to prevent the virus from becoming endemic in the country. Adequate care for patients with chikungunya fever requires training general practitioners, rheumatologists, nurses, and experts in laboratory diagnosis. Up to November 2014, more than 1,000 cases of the virus were reported in Brazil. There is a need for experimental studies in animal models to understand the dynamics of infection and the pathogenesis as well as to identify pathophysiological mechanisms that may contribute to identifying effective drugs against the virus. Clinical trials are needed to identify the causal relationship between the virus and serious injuries observed in different organs and joints. In the absence of vaccines or effective drugs against the virus, currently the only way to prevent the disease is vector control, which will also reduce the number of cases of dengue fever.
o objetivo deste estudo foi mostrar, com base na literatura sobre o tema, o potencial de dispersão e estabelecimento do vírus chikungunya no brasil. O vírus chikungunya, um Togaviridae do gênero Alphavirus, atingiu as Américas em 2013 e, no ano seguinte, mais de um milhão de casos foram notificados. No Brasil, foi registrada transmissão autóctone no Amapá e Bahia, mesmo durante o período de baixo índice pluviométrico, expondo ao risco de propagação do vírus todo o território nacional. Historicamente, o Brasil é infestado por Ae. Aegypti e Ae. Albopictus, também vetores do dengue. É possível que o chikungunya se dissemine, sendo importante que medidas sejam tomadas para evitar que o vírus se torne endêmico no País. A adequada assistência a pacientes com febre de chikungunya requer treinamento de clínicos, reumatologistas, enfermeiros e especialistas em diagnóstico laboratorial. Até novembro de 2014 foram notificados no Brasil mais de 1.000 casos da virose. Estudos experimentais em modelos animais devem ser realizados para conhecer a dinâmica da infecção e a patogenia, bem como identificar mecanismos fisiopatológicos que possam contribuir para identificar drogas com efeito sobre o vírus. São necessários ensaios clínicos para identificar a relação causal do vírus com sérias lesões observadas em diferentes órgãos e nas articulações. Na ausência de vacinas ou drogas efetivas contra o vírus, a única forma de prevenir a doença é atualmente o controle vetorial, o que também reduzirá o número de casos de dengue.
Asunto(s)
Humanos , Animales , Virus Chikungunya , Aedes/clasificación , Fiebre Chikungunya/epidemiología , Insectos Vectores/clasificación , Brasil , Factores de Riesgo , Notificación de Enfermedades , Fiebre Chikungunya/transmisiónRESUMEN
Os rotavírus são considerados a principal causa de gastrenterite grave em crianças abaixo de cinco anos, principalmente nos países em desenvolvimento. A vacinação nos primeiros meses de vida se constitui na medida mais efetiva em saúde pública para o controle e prevenção das infecções por tais agentes. Não obstante o recente licenciamento de duas vacinas para uso corrente em lactentes (Rotarix® e RotaTeq®), as pesquisas prosseguem com novas alternativas de prevenção e tratamento. Neste contexto, procedeu-se à reanálise da Rhesus-Human Reassortant Rotavirus Tetravalent Vaccine (RRV-TV), com ênfase à eficácia clínica frente aos parâmetros clínicos, aos sorotipos mais prevalentes na região, à ocorrência de eventos adversos graves (intussuscepção) e a proteção seletiva aos quadros de maior gravidade. Os dados clínicos e epidemiológicos foram obtidos das fichas clínicas de 91 episódios diarreicos em crianças no âmbito de uma investigação prévia conduzida em Belém, Pará. Foram considerados como indicadores de gravidade, os parâmetros clínicos e um sistema de escores, comumente aplicado aos estudos de eficácia da RRV-TV. Os resultados mais expressivos do estudo, como a significativa proteção (p 14 relacionados ao sorotipo G2, a eficácia de 75 por cento contra os episódios mais graves, são discutidos à luz do contexto atual dos conhecimentos sobre o tema.
Rotaviruses are considered the leading cause of severe gastroenteritis in children under five years of age, especially in developing countries. Vaccination in the first months is the most effective public health action for the control and prevention of infections by such agents. Despite the recent licensing of two vaccines for use in infants (Rotarix® and Rota Teq®), researchers continue to seek new alternatives for prevention and treatment. Herein, we provide a review of the Rhesus-Human Reassortant Rotavirus Tetravalent Vaccine (RRV-TV), with an emphasis on its clinical efficacy as regards clinical parameters, the most prevalent serotypes in the region, the occurrence of severe adverse events (e.g., intussusception), and selective protection in the most severe cases. The clinical and epidemiological data were obtained from medical records pertaining to 91 episodes of diarrhea among children in a previous investigation conducted in Belém, Pará State, Brazil. Clinical patterns and a scoring system commonly used in studies on the efficacy of RRV-TV were considered as indicators of severity. The most impressive results of this study, such as a significant protection (p 14 related to serotype G2, a 75 percent efficacy rate against severe episodes, and the non-occurrence of intussusception, are discussed in the context of current knowledge on this issue.
Asunto(s)
Masculino , Femenino , Humanos , Recién Nacido , Niño , Gastroenteritis , Rotavirus , Infecciones por Rotavirus , Vacunas contra Rotavirus , Ensayo de Inmunoadsorción Enzimática/métodosRESUMEN
The importance of norovirus (NoVs), sapovirus (SaVs) and human astrovirus (HAstVs) as causes of gastroenteritis outbreaks are already well-defined, but a few studies have described sporadic cases of acute gastroenteritis caused by these viral entities. The aim of this study was to determine the role of these viruses in the etiology of acute gastroenteritis in children enrolled to participate in hospital and emergency department based intensive surveillance carried out in Belém, Brazil, from March to September 2003. A total of 305 stool specimens from patients with severe gastroenteritis were collected and screened by reverse transcription followed by polymerase chain reaction (RT-PCR), using the specific primers Mon 269 and Mon 270 for HAstVs, p289 and p290 for human calicivirus (HuCVs), and Mon 431/433 and Mon 432/434 for NoVs. Sequencing of RT-PCR HAstV, HuCVs and NoVs amplicons was carried out using the same primers. Of the 305 samples tested, 96 (31.5 percent) were positive, with 51 diagnosed as HuCVs, 40 as HAstVs and five as mixed infections. Of the 56 (18.4 percent) HuCVs sequenced, 30 were NoVs (9.8 percent) of genogroups GI-4 and GII-4, and 15 (4.9 percent) were SaVs of types GI-1, GI-2 and GII-1. HAstVs, including genotypes 1, 8 and 2, were detected in 45 (14.7 percent) samples. This study has highlighted the importance of these viruses as causes of acute gastroenteritis and established the circulation of different genotypes during the study period. These results reinforce the need for establishing an intensive surveillance for gastroenteritis caused by these viruses to assess the burden of disease and to monitor the circulation of genotypes.
A importância dos norovírus (NoVs), sapovírus (SaVs) e astrovírus humanos (HAstVs) como causa de surtos de gastroenteritis já está bem definida. Entretanto, poucos estudos têm descrito casos esporádicos de gastroenterites aguda causados por esses agentes. O objetivo deste estudo foi determinar o papel destes vírus na etiologia da gastroenterite aguda em crianças atendidas durante uma vigilância intensiva realizada em hospitais e ambulatórios de Belém, Brasil, de março a setembro de 2003. Um total de 305 espécimes fecais de pacientes com gastrenterite grave foram coletados e testados por reação em cadeia da polimerase precedida de transcrição reversa (RT-PCR), utilizando iniciadores específicos Mon 269 e Mon 270 para os HAstVs; p289 e p290 para os calicivírus humanos (HuCVs); e Mon 431/433 e Mon 432/434 para os NoVs. Sequenciamento dos amplicons de HAstV, HuCVs e NoVs, obtidos por RT-PCR, foi realizado usando os mesmos iniciadores. Das 305 amostras testadas, 96 (31,5 por cento) apresentaram resultados positivos, sendo que 51 diagnosticadas como HuCVs, 40 como HAstVs e cinco infecções mistas. Das 56 (18,4 por cento) amostras de HuCVs sequenciadas, 30 foram NoVs (9,8 por cento) pertencentes aos genogrupos GI-4 e GII-4, e 15 (4,9 por cento) SaVs dos grupos GI-1, GI-2 e GII-1. HAstVs foram detectados em 45 (14,7 por cento) das amostras, incluindo os genótipos 1, 8 e 2. Esta pesquisa ressalta a importância destas viroses como causa de gastrenterite aguda e demonstra a circulação de diferentes genótipos durante o período de estudo. Estes resultados reforçam a necessidade de se estabelecer uma vigilância intensiva das gastrenterite causadas por estes vírus, de forma a poder avaliar o impacto da doença e monitorar os genótipos circulantes.
Asunto(s)
Masculino , Femenino , Humanos , Niño , Gastroenteritis/etiología , Mamastrovirus , Norovirus , Sapovirus , Infecciones por Astroviridae , Infecciones por Astroviridae/diagnóstico , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa/métodosRESUMEN
Um total de 234 crianças e adolescentes, menores de 16 anos (média de idade = ñ 5,8 anos), com suspeita clínica de mononucleose infecciosa, foi atendido no "Serviço de Virologia Geral" do "Instituto Evandro Chagas (IEC)", no período de junho a dezembro de 1995. As amostras de soro foram testadas quanto à presença de anticorpos das classes IgG e IgM anti-Epstein Barr (EBV), através do procedimento imunoenzimático (ELISA), especificamente contra o antígeno do capsídeo viral (anti-VCA). Para tanto se utilizou o Kit da Clark Laboratories(tm) (Jamestown - NY - EUA). O objetivo deste trabalho foi de estabelecer a frequência de infecçäo primária pelo EBV, avaliando as características clínicas em crianças e adolescentes. Dentre as 234 amostras analisadas a soropositividade em termos de IgG foi de 56 por cento (131/234), sendo que 55 por cento (72/131) e 45 por cento (59/131) eram do sexo masculino e feminino, respectivamente. Em 10,6 por cento (25/234) das crianças e adolescentes com mononucleose infecciosa ativa (presença de anticorpos IgM-EBV), registramos os seguintes achados clínicos: linfadonopatias (76 por cento), febre (68 por cento), erupçäo cutânea (12 por cento) e hepatomegalia (12 por cento). Os resultados indicam que, já aos seis anos de idade, metade das crianças já foram infectadas pelo EBV